Literature DB >> 1865923

Common west African HLA antigens are associated with protection from severe malaria.

A V Hill1, C E Allsopp, D Kwiatkowski, N M Anstey, P Twumasi, P A Rowe, S Bennett, D Brewster, A J McMichael, B M Greenwood.   

Abstract

A large case-control study of malaria in West African children shows that a human leucocyte class I antigen (HLA-Bw53) and an HLA class II haplotype (DRB1*1302-DQB1*0501), common in West Africans but rare in other racial groups, are independently associated with protection from severe malaria. In this population they account for as great a reduction in disease incidence as the sickle-cell haemoglobin variant. These data support the hypothesis that the extraordinary polymorphism of major histocompatibility complex genes has evolved primarily through natural selection by infectious pathogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865923     DOI: 10.1038/352595a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  361 in total

1.  Major histocompatibility complex variation in the endangered Przewalski's horse.

Authors:  P W Hedrick; K M Parker; E L Miller; P S Miller
Journal:  Genetics       Date:  1999-08       Impact factor: 4.562

Review 2.  Science, medicine, and the future: susceptibility to infection.

Authors:  D Kwiatkowski
Journal:  BMJ       Date:  2000-10-28

3.  The relation between HLA-DQA1 genes and genetic susceptibility to duodenal ulcer in Wuhan Hans.

Authors:  Yi-Ping Du; Chang-Sheng Deng; De-Yin Lu; Mei-Fang Huang; Shu-Fang Guo; Wei Hou
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

4.  Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

Authors:  R Hermann; M Knip; R Veijola; O Simell; A-P Laine; H K Akerblom; P-H Groop; C Forsblom; K Pettersson-Fernholm; J Ilonen
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

5.  Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.

Authors:  Amadou Kone; Bassirou Diarra; Keira Cohen; Seydou Diabate; Bourahima Kone; Mahamane T Diakite; Hawa Diarra; Moumine Sanogo; Antieme C G Togo; Yeya Dit Sadio Sarro; Bocar Baya; Nadie Coulibaly; Ousmane Kodio; Chad J Achenbach; Robert L Murphy; Jane L Holl; Sophia Siddiqui; Seydou Doumbia; William R Bishai; Souleymane Diallo; Mamoudou Maiga
Journal:  HLA       Date:  2019-01-02       Impact factor: 4.513

6.  HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance.

Authors:  A G White; J Bogh; W Leheny; P Kuchipudi; M Varghese; H al Riyami; S al Hashmi; A S Daar
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

7.  Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.

Authors:  Alexander G Maier; Manoj T Duraisingh; John C Reeder; Sheral S Patel; James W Kazura; Peter A Zimmerman; Alan F Cowman
Journal:  Nat Med       Date:  2002-12-09       Impact factor: 53.440

8.  Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.

Authors:  Diego Chowell; Luc G T Morris; Claud M Grigg; Jeffrey K Weber; Robert M Samstein; Vladimir Makarov; Fengshen Kuo; Sviatoslav M Kendall; David Requena; Nadeem Riaz; Benjamin Greenbaum; James Carroll; Edward Garon; David M Hyman; Ahmet Zehir; David Solit; Michael Berger; Ruhong Zhou; Naiyer A Rizvi; Timothy A Chan
Journal:  Science       Date:  2017-12-07       Impact factor: 47.728

9.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production.

Authors:  S Picot; F Peyron; P Deloron; C Boudin; B Chumpitazi; G Barbe; J P Vuillez; A Donadille; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.